The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis

Toll-like receptors (TLRs) are key players in the pathogenesis of inflammatory conditions including coronary arterial disease (CAD). They are expressed by a variety of immune cells where they recognize pathogen-associated molecular patterns (PAMPs). TLRs recruit adaptor molecules, including myeloid...

Full description

Bibliographic Details
Main Authors: Roshan, Mohsin H. K., Tambo, Amos, Pace, Nikolai P.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067326/
id pubmed-5067326
recordtype oai_dc
spelling pubmed-50673262016-10-30 The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis Roshan, Mohsin H. K. Tambo, Amos Pace, Nikolai P. Review Article Toll-like receptors (TLRs) are key players in the pathogenesis of inflammatory conditions including coronary arterial disease (CAD). They are expressed by a variety of immune cells where they recognize pathogen-associated molecular patterns (PAMPs). TLRs recruit adaptor molecules, including myeloid differentiation primary response protein (MYD88) and TIRF-related adaptor protein (TRAM), to mediate activation of MAPKs and NF-kappa B pathways. They are associated with the development of CAD through various mechanisms. TLR4 is expressed in lipid-rich and atherosclerotic plaques. In TLR2−/− and TLR4−/− mice, atherosclerosis-associated inflammation was diminished. Moreover, TLR2 and TLR4 may induce expression of Wnt5a in advanced staged atheromatous plaque leading to activation of the inflammatory processes. TLR9 is activated by CpG motifs in nucleic acids and have been implicated in macrophage activation and the uptake of oxLDL from the circulation. Furthermore, TLR9 also stimulates interferon-α (INF-α) secretion and increases cytotoxic activity of CD4+ T-cells towards coronary artery tunica media smooth muscle cells. This review outlines the pathophysiological role of TLR2, TLR4, and TLR9 in atherosclerosis, focusing on evidence from animal models of the disease. Hindawi Publishing Corporation 2016 2016-10-04 /pmc/articles/PMC5067326/ /pubmed/27795867 http://dx.doi.org/10.1155/2016/1532832 Text en Copyright © 2016 Mohsin H. K. Roshan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Roshan, Mohsin H. K.
Tambo, Amos
Pace, Nikolai P.
spellingShingle Roshan, Mohsin H. K.
Tambo, Amos
Pace, Nikolai P.
The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
author_facet Roshan, Mohsin H. K.
Tambo, Amos
Pace, Nikolai P.
author_sort Roshan, Mohsin H. K.
title The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
title_short The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
title_full The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
title_fullStr The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
title_full_unstemmed The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
title_sort role of tlr2, tlr4, and tlr9 in the pathogenesis of atherosclerosis
description Toll-like receptors (TLRs) are key players in the pathogenesis of inflammatory conditions including coronary arterial disease (CAD). They are expressed by a variety of immune cells where they recognize pathogen-associated molecular patterns (PAMPs). TLRs recruit adaptor molecules, including myeloid differentiation primary response protein (MYD88) and TIRF-related adaptor protein (TRAM), to mediate activation of MAPKs and NF-kappa B pathways. They are associated with the development of CAD through various mechanisms. TLR4 is expressed in lipid-rich and atherosclerotic plaques. In TLR2−/− and TLR4−/− mice, atherosclerosis-associated inflammation was diminished. Moreover, TLR2 and TLR4 may induce expression of Wnt5a in advanced staged atheromatous plaque leading to activation of the inflammatory processes. TLR9 is activated by CpG motifs in nucleic acids and have been implicated in macrophage activation and the uptake of oxLDL from the circulation. Furthermore, TLR9 also stimulates interferon-α (INF-α) secretion and increases cytotoxic activity of CD4+ T-cells towards coronary artery tunica media smooth muscle cells. This review outlines the pathophysiological role of TLR2, TLR4, and TLR9 in atherosclerosis, focusing on evidence from animal models of the disease.
publisher Hindawi Publishing Corporation
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067326/
_version_ 1613686905061244928